Personalized Cancer Vaccines: A New Hope in the Fight Against the Disease
Table of Contents
In laboratories around the world, patients in remission cross their fingers: what if the next treatment was finally good? An unexpected advance has just shaken the medical community, promising to change the game in the fight against cancer. Zoom in on these personalized vaccines that draw a new hope and challenge prejudices of conventional treatments.
The bet of tailor-made vaccines: When the treatment marries the patient
Understand the promise Personalized vaccines
Until today, the war on cancer relied on “one size all” strategies: chemotherapy, immunotherapy and radiotherapy, applicable on a large scale. But each cancer is unique and each patient is just as much. this is where the new personalized anti-cancer vaccines come in: they are designed from the genetic specificities specific to the tumor of each person. Thanks to this tailor-made approach, the ambition is clear: teaching the immune system of each patient to precisely target the cancer cells of their own body.
Why these vaccines could upset the Cancer management
This promise upsets the established codes. So far, it has not been possible that a vaccine treats cancer already declared. Though, the first returns show that these treatments could reduce the risk of relapse, limit the usual side effects and, in certain cases, considerably prolong the survival of patients previously considered to be “without resources”. Given the diversity of cancers, it is indeed a real revolution that is announced in french hospitals and beyond.
Clinical tests to the spectacular results
Of first successes that exceed all expectations
As of this year, the first patients who benefited from these individualized vaccines experienced a notable advancement in their state. For some, recurrences have spaced themselves; For others, we observe a almost complete disappearance of traces of the disease after regular vaccine injection. This success, still unimaginable five years ago, arouses hope for a paradigm change in anti-cancer care.
figures that make Dreaming oncologists and patients
Statistics, though still very cautious, show a relapse rate reduced from 45 % to 60 % in patients treated with this new generation of vaccines. A hope reinforced by the relative simplicity of the protocol: one to five injections, often well tolerated, without the usual undesirable effects of chemotherapy.
Manufacturing secrets: The haute couture of medicine
genetic portraits for A unique vaccine
Each vaccine is a unique piece, fruit of a ultra-precise genetic portrait. Using a simple biopsy, researchers analyze the sequencing of tumor cells. It is this personal “barcode” of cancer that will be used to make a vaccine targeting only sick cells, while saving healthy cells.
A process accelerated by intelligence artificial and biotechnology
This advance would not have been possible without the combined help of biotechnology and artificial intelligence. Today, it only takes a few weeks to go from the analysis of the levy to the production of a ready-to-use vaccine. This accelerated rhythm, unimaginable still recently, has been made possible by high-tech platforms capable of automating analyzes and manufacturing on demand.
patients at heart of innovation
Men’s and women’s journey: testimonials from those who have benefited from it
In France as elsewhere, patients express their surprise, their relief and, sometimes, their disbelief on the effectiveness of this